SCHEMBL6950313

SCHEMBL6950313

Cc1ccc(F)c2[nH]cnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.41
PDPK1 O15530 3/20 0.38
CSNK2A1 P68400 3/20 0.36
CSNK2A2 P19784 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
CSNK2B P67870 1/20 0.36
KMT2A Q03164 1/20 0.36
DYRK1A Q13627 1/20 0.36
CSNK2A3 Q8NEV1 1/20 0.36
ABL1 P00519 1/20 0.33
RAD52 P43351 1/20 0.33
RIN1 Q13671 1/20 0.33
HSP90AB1 P08238 1/20 0.33
HSD17B10 Q99714 2/20 0.33
BRD4 O60885 2/20 0.32
CHEK1 O14757 1/20 0.32
ACP1 P24666 1/20 0.32
TGFBR1 P36897 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950307 0.84 PARP1 (0.41) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL15800772 0.83 PARP1 (0.46) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL4560164 0.83 PARP1 (0.46) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL13184288 0.76 CSNK2A1 (0.41) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL4612063 0.76 PARP1 (0.41) PARP1HTT
SCHEMBL24197720 0.76 PDE2A (0.36) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL13156101 0.73 PDPK1 (0.40) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL20200118 0.72 PDPK1 (0.46) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL14347716 0.72 ALDH1A1 (0.39) PARP1PDPK1CSNK2A1CSNK2A2RAB9A
SCHEMBL14035178 0.71 KDM5A (0.44) PARP1PDPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180434-A1 PB2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Haisco Pharmaceutical Co., Ltd. (CN) 2023-05-17 EP disclosed
WO-2022007966-A1 PB2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川海思科制药有限公司 2022-01-13 WO disclosed
EP-0736022-B1 5-(2-IMIDAZOLINYLAMINO)BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ALPHA-2 ADRENOCEPTOR AGONISTS PROCTER & GAMBLE (US) 2003-09-24 EP disclosed
US-5691370-A 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 1997-11-25 US disclosed
EP-0736022-A1 5-(2-IMIDAZOLINYLAMINO)BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1996-10-09 EP disclosed
US-5541210-A ANALGESICS, ANTIINFLAMMATORY AGENTS, ANTIHISTAMINES OR COUGH MEDICINE THE PROCTER & GAMBLE COMPANY (US) 1996-07-30 US disclosed
US-5478858-A Respiratory system disorders, gastrointestinal disorders THE PROCTER & GAMBLE COMPANY (US) 1995-12-26 US disclosed
WO-1995016685-A1 5-(2-IMIDAZOLINYLAMINO)BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1995-06-22 WO disclosed